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The  term  "reticuloendothelial blockade"  (RE  blockade)  denotes  the  im- 
paired  blood stream  clearance which follows intravenous injections of large 
doses of particulate material. Such blockade has been generally considered to 
result from physical saturation of RE cells  by phagocytosis of the particles 
injected  (1-3).  However, a  number of studies have indicated that blockade 
is quite specific and is demonstrable only when the material used to test for 
the presence of blockade has the same surface characteristics as the blockad- 
ing agent [4-8). 
Two other theories have thus been proposed to account for this specificity: 
first, that the blockading close results in the depletion of serum opsonins specific 
for the surface of the partide  under study (5,  9);  or second, that there are 
"particle-specific"  macrophage  clones  in  the  RE  system  (6).  Experiments 
reported from this laboratory in  1965 could not confirm either of these hy- 
potheses (7).  In these studies RE blockade induced by gelatin-stabilized col- 
loids could not be explained by saturation of RE ceils or by the depletion of 
serum opsonins but was instead dependent on the simple continuing circula- 
tion of the gelatin-blockading dose. 
Most investigations of RE blockade have employed colloidal materials, such 
as carbon or gold which are  gelatin stabilized (1-3,  5,  7, 9). Because gelatin 
persists for long periods  in  the  circulation,  the present  studies were  under- 
taken to characterize blockade in a  system free of exogenous stabilizing ma- 
terial. For these purposes a  simple, inert, particulate material, chromic phos- 
phate, suspended in 5 % dextrose, was employed. 
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Materials  and Methods 
Experimental  Animals.--Female  Wistar  albino  rats  weighing  between  225  and 
325 g were used for all experiments. 
Particulate Materials.--Both  untagged  and  s~P-labded  chromic  phosphate  were 
prepared  by the method  of Dobson  (4).  Sodium acetate,  chromic nitrate,  and  di- 
sodium phosphate (Fisher Scientific  Company, Fair Lawn, N. J.) were appropriately 
reacted and the resulting purple hexahydrate of chromic phosphate was converted to 
the dark gray anhydrous and insoluble compound by heating at 650°C for 12-18 hr. 
Appropriate amounts of riP-labeled disodium phosphate obtained from Volk Radio- 
chemical Co., Burbank,  Calif.,  were included in the reaction mixture  to make the 
radiolabeled chromic phosphate. Particles of the desired size range were produced by 
mechanical grinding in a ball mill followed by differential centrifugafion. Particle sizes 
were measured by means of a  calibrated eyepiece micrometer mounted on a  simple 
light microscope. Except in specified instances, the particles utilized ranged from 0.8 
to  1.0  /z and  below.  Electron microscopy demonstrated  that  many particles  were 
smaller than this (see Fig. 1). Particles of this size produced stable suspensions in 5% 
dextrose in water. The suspensions utilized were sterile  and pyrogen-free. 
Untagged chromic phosphate (CP) suspended in 5 % glucose in water in concentra- 
tions of 125-175  mg/ml was used to produce RE blockade. The standard tracer dose of 
chromic phosphate (8~CP) consisted of 0.4-0.7 mg of tracer suspended in 0.I ml of 5% 
glucose in water. The specific activity of the tracer at the time of preparation ranged 
from 30 to 50/zc/mg. In experiments designed to study the clearance characteristics 
of the blockading dose itself,  large doses  of chromic phosphate  with lesser  specific 
activity of ~P (0.06-0.08  ~c/mg) were utilized. 
Radioactive  colloidal  gold  (1~Au) stabilized  with  0.3%  salt-free  gelatin  with  a 
specific activity of 58/~c/ml was obtained from Abbott Laboratories, North Chicago, 
Ill. The standard tracer dose consisted of 20 tzc of l~Au. 
Clearance Studies in Living Rats.--Animals were anesthetized by the intraperitoneal 
administration  of 4 rag/100 g body weight of pentobaxbital  sodium,  and  a  trache- 
ostomy was performed. The left femoral and right jugular veins were cannulated with 
PE-50-polyethylene catheters and patency maintained with small amounts of heparin. 
In experiments concerned with the effects of RE blockade, untagged CP was injected 
via the femoral cannula 60 rain prior to the administration of radioactive tracer by the 
same route. When blockading doses were administered more than 1 hr prior to tracer, 
the tail vein route was used,  and anesthesia  and cannula  placement withheld until 
30 rain before tracer injection. 0.2 ml blood samples were withdrawn from the jugular 
cannula at appropriate intervals following tracer administration and placed in heparin- 
ized  tubes.  0.1  ml  aliquots  were  transferred  to aluminum  planchets  and 3~CP was 
counted in a gas-flow,  thin-window proportional counter. When l~Au was employed, 
tubes were counted directly in a well-type scintillation counter. Clearance curves were 
constructed to show the log of the per cent of radioactivity remaining in the blood 
stream at each sampling period utilizing the 1 rain sample as the 100% value. 
Clearance Studies in  Isolated Perfused Live~'s.--Both  normal  and  "blockaded" 
animals  were  used  in  isolated  perfused  liver  experiments.  The  blockaded  animals 
were given an intravenous  injection of  1000 mg/kg of untagged  CP  1-3 hr before 
study. Both normal and blockaded animals were then anesthetized with pentobarbital, DRUTZ~ KOENIG~ AND ROGERS  1089 
the abdomen opened, the liver isolated, and polyethylene inflow and outflow catheters 
placed in the portal vein and proximal inferior vena cava. The inferior vena cava was 
damped just above the renal veins. Krebs-Henseleit buffer solution, pH 7.4, was then 
used to perfuse the liver employing methods previously described  which  permitted 
maintenance of normal portal pressures of 10 cm of water, a  temperature of 39°C, 
and flow rates of approximately 16 ml/min (7). The liver was initially rinsed through 
with  100-150 ml of Krebs-Henseleit buffer to remove contained blood.  1 ml of the 
~CP suspension  was then added to 100 ml of the buffer solution  and four pairs of 
simultaneous inflow-outflow samples were drawn as it was perfused.  The percentage 
uptake was calculated from the  difference  of the  averages of these paired inflow- 
outflow samples as previously described  (7). When more than one experiment was per- 
formed in a given liver, the liver was perfused with 100 ml of Krebs-Henseleit buffer 
before the next perfusate was employed. 
Opsoniz~tion Studies.--(a)  Homologous serum was obtained by cardiac puncture 
from ether-anesthetized female Wistar rats. The serum was immediately separated, 
frozen in dry-ice and ethanol, and stored at  -70°C until needed.  (b) Isologous serum 
was obtained from femoral cannula bleeding  of pentabarbital-anesthetized rats prior 
to the administration of the untagged  CP-blocking  dose. Serum was separated, and 
used within 1 hr. 
30 min following administration of the blocking  dose, the standard tracer dose of 
aCP was placed in 0.33-1.0 ml of either homologous or isologous serum, incubated at 
37°C for 30 min on a rotating drum, and employed in the appropriate clearance study. 
RESULTS 
Clearance  of  the  Standard  Tracer  Dose  of  Chromic  Phosphate  in  Normal 
Rats.--Blood  stream clearance  curves  obtained  in  10  normal  rats  given  the 
standard  tracer  dose  of ~P-labeled  chromic  phosphate  (~CP)  were  uniform 
and predictable.  As noted  in Text-fig.  1,  clearance appeared composed of at 
least two exponentials, with an initial rapid phase lasting 10-15 rain, followed 
by abrupt slowing. Less than 1% of the injected CP remained in the circula- 
tion  at  60  rain.  Examination  of histologie  sections  showed heavy uptake  of 
chromic phosphate in the liver and spleen; it could not be visualized in other 
organs. 
Chromic Phosphate Blockade.--Injections  of 750  or 1000 mg/kg of untagged 
chromic  phosphate  produced  marked  impairment  of  the  32Cp tracer  dose 
clearance  administered  1  hr  later.  These  studies  are  shown  in  Text-fig.  2. 
Blockading  doses  up  to,  and  often  including,  500  mg/kg failed  to  produce 
significant changes in clearance. To eliminate the possibility of a  latent  period 
before blockade was detectable  (10,  11),  tracer doses were administered from 
3  to  24  hr  following injection  of  100  mg/kg  of the  untagged  material.  No 
evidence of impairment of tracer clearance was obtained in these studies. 
The effect of the  increasing doses of untagged  CP  on the  clearance  haft- 
time  (T~,~)  of 32CP tracer administered  1  hr  later are shown in Text-fig. 3. 
Uniform prolongation of the T~/~ was not seen until doses exceeded 500 mg/kg 1090  MECHANIS~  O~F RETICULOENDOTHELIAL  BLOCKADE 
and then appeared directly related to the blockading dose employed. Blockade 
persisted in diminishing  degree for 48-72 hr. 
Specificity  of Blockade.--The  specificity of CP blockade was studied using 
radiogold as the test particle. Tracer doses of 198Au administered 1 hr following 
doses of untagged CP, shown to markedly inhibit tracer ~CP clearance,  were 
cleared normally  (Text-fig.  4).  It  thus  appeared that  CP blockade had  sig- 
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TEXT-FIG. I. Range of  blood stream clearance  curves obtained in I0 normal rats  given the 
standard tracer  dose of chromic phosphate ~2Cp). 
be explained  on  the  basis  of  generalized  depression  of  RE  phagocytic  cell 
function. 
Fale of the Blockading  Dose.--Because of the apparent direct relationship be- 
tween the degree of blockade and the size of the blockading dose administered, 
the fate of the large doses of CP employed to blockade the RE system was 
determined.  In such studies the clearance  of large doses of CP labeled with 
~P was examined.  As shown in Text-fig.  5, doses below 250 mg/kg cleared at 
rates closely paralleling  those of the standard tracer dose. Above these doses, 
there was progressive delay of clearance  which was proportional to the dose 
of CP employed. Significant  quantities of CP were always in the circulation 
1 hr  following  the  injection  of doses producing  apparent  blockade at  1 hr. 
Microscopic examination  of liver  sections  showed visible  CP  in  phagocytic DRUTZ,  KOENIG,  AND  ROGERS  1091 
cells, free in the vascular system, and lining the endothelium of hepatic sinusoids 
at the time blockade was demonstrable (see Figs. 2 a and 2 b). 
Studies  in  the  Isolated  Perfused  Rat  Liver.--The  above  studies  suggested 
that during the first few hours following the injection of the blockading dose, 
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TEXT-I~o. 2.  Chromic phosphate blockade. The effect of large doses of untagged  chromic 
phosphate given 1 hr before tracer dose of a2CP. Doses of 750-1000 mg of CP markedly de- 
ayed clearance of ~CP. 
untagged "blocking" CP still in the process of being cleared. To eliminate the 
possibility that such blockade was due to changes in RE phagocytic ceils per 
se, studies were performed in isolated, perfused livers. 
The  livers from normal animals were highly efficient in  removing tracer 
from  the  perfusate  and  examination  of  microscopic  sections  showed  both 
Kupffer's cell  incorporation  and  intravascular  trapping  of  the  82Cp (Figs. 
3 a-3 c). Further, as noted in Text-fig. 6; 8~CP tracer was removed in an identical 
fashion and with similar efficiency when perfused through "blockaded" livers. 
Effect of Particle Size on Blockade.--The  preceding studies suggested that 
blockade was more closely related to the quantity of blockading material still 1092  M3ECHANISM OF RETICULOENDOTHELIAL BLOCKADE 
BLOCKADING  HALF-TIME,  CHROMIC  PHOSPHATE  (3ZCP)  CLEARANCE 
DOSE 
NONE  ~',',',',',',',',',~ 
NORMAL 
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TExT-FzG. 3.  The effect of increasing amounts  of untagged  chromic phosphate  on the 
clearance half-time (T~) of ~CP. The tracer dose was administered 1 hr after the blockading 
dose. 
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T~xT-Fm. 4.  Specificity of blockade. Large doses of untagged chromic phosphate had little 
effect on clearance of tracer doses of radiogold (l~Au). The shaded  curve represents lSSAu 
clearances obtained in 10 normal rats. Four rats receiving 750-1000  mg/~g of chromic phos- 
phate had normal radiogold clearances.  The two animals which received 1000 mg/kg of chromic 
phosphate showed markedly impaired a~CP clearance. DRUTZ~  KOENIG~  AND  ROGERS  1093 
circulating at the time of injection of the tracer than to the amount of untagged 
CP  present  in  the  RE  cells.  Because  other  investigators  have  shown  that 
small particles are cleared from the circulation more slowly than large particles 
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T~sz-Fzo. 5. Fate of blockading dose.  Significant  quantities  of the blockading dose were 
present in the circulation  1 hour after  administration  of  doses of 500 mg/kg or above. 
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TEXT-I~o. 6.  The removal of chromic phosphate by five normal and four blockaded per- 
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T~xT-Fm. 7.  Effect of particle size on blockade. Blockading doses were maintained at 1000 
mg/kg, but the particle size was varied. Each curve represents the clearance observed in three 
or more animals. 
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T~xT-~'ko. 8.  Effect of opsonization on blockade. In the experiment on the left,  a  tracer 
dose of 32CP was given 1 hour after blockade. This was followed 1 hr later by a  second  tracer 
dose of 0.1  ml ~CP, opsonized in 0.9 ml of fresh isologous serum. In the  experiment on the 
right, the sequence of opsonized and nonopsonized tracers was reversed. In neither  instance 
did opsonization alter tracer clearance. DRUTZ,  KOENIG,  AND  ROGERS  1095 
large in producing blockade if persistence of the blockading dose in the circula- 
tion was of importance in the process. 
As noted in Text-fig. 7, demonstrable blockade was progressively increased 
as the particle size  of the blockading dose was decreased from 2.5  to  1.0 tz. 
Moreover, it was possible to reduce the dose of CP necessary to produce block- 
ade by progressive reductions in particle size. 
Opsonization Studies.--Smaller  particles which more easily induced blockade 
also presented a  significant increase in total surface area of CP. It was thus 
postulated that large numbers of small particles might more readily deplete 
the blood of opsonins necessary for CP phagocytosis. Therefore, experiments 
were conducted to test this hypothesis. 
No  evidence of the importance of serum opsonins in the  clearance of CP 
could be  obtained.  In four separate  experiments performed in four different 
animals, incubation of the 3~CP tracer in fresh isologous serum failed to improve 
clearance of the tracer in blockaded animals. One such experiment is shown 
in Text-fig. 8. Similarly, incubation of the mCP tracer in homologous serum in 
three separate experiments failed to alter clearance of the tracer in blockaded 
rats. 
DISCI3 SSION 
The  demonstration  that  particulate  chromic phosphate  suspended in 5 7o 
dextrose  in water  could produce  reticuloendothelial blockade indicates  that 
this phenomenon is not dependent on the presence  of exogenous stabilizing 
materials such as gelatin. As in previous studies (4-8),  the RE blockade in- 
duced demonstrated significant specificity. Thus,  blockade could not be  ex- 
plained on the basis of saturation of the entire phagocytic cell population of the 
RE system. The fact that isolated perfused "blockaded" livers could take up 
chromic phosphate in a fashion identical to normal livers appeared to eliminate 
saturation of particle-specific cell clones as a likely explanation for the delays 
in  tracer  clearance observed.  Blockade could not be  explained on the basis 
of depletion of serum opsonins. Fresh isologous serum utilized to assure the 
replacement of opsonin identical to that which had presumably been depleted 
by the blockading dose failed to eliminate impaired clearance of tagged 8~CP. 
Furthermore,  the use of nonisologous sera  also failed to overcome blockade 
although it has been suggested that incubation with foreign serum may change 
the particle surface to one for which opsonins are still present in the blood 
stream (5). Thus our experience was similar to that of Biozzi and his coworkers, 
who were unable to demonstrate a role for serum opsonins in RE blockade (3). 
For  at  least  the first  several  hours following its  induction,  RE  blockade 
with  chromic phosphate  appeared  to  relate  more  to  those  particles  still  in 
circulation outside the cells than to those within. This finding is similar to that 
reported in previous studies utilizing gelatin as the blockading agent (7). 
The effect of particle size on blockade was striking. It has been shown that 1096  MECHANISM  OF RETICULOENDOTHELIAL  BLOCKADE 
the efficiency with which particulate material is cleared by the RE system is 
directly related to the size of the particles injected (4, 12-15).  Small particles 
tend to remain in circulation  longer. Thus, the apparent enhancement of block- 
ade  resulting from reductions in particle  size might  relate  to  the prolonged 
presence  of small  particles  outside  the  cells.  Perhaps  sufficient  numbers  of 
particles external to phagocytic cells adversely affect cell membrane recogni- 
tion phenomena. On the other hand, reductions of particle size are accompanied 
by increases  in  particle  numbers  when dosage is  held  constant.  Thus,  it  is 
conceivable that blockade occurs because membrane-binding sites are saturated 
rather than from physical cellular stuffing when increased  numbers of particles 
are presented  to the RE system. The demonstration of normal clearance  by 
blockaded livers in these and previous studies (7) might result from the removal 
of significant  amounts of blockading material from such binding sites by the 
preliminary  buffer perfusion.  As a  result,  binding  sites would again  become 
available for subsequent tracer  attachment.  The presence of specific cellular 
binding sites for specific particle types might also explain  the phenomenon of 
specificity. 
The doses of chromic phosphate required to produce blockade in the present 
studies were much greater than those utilized by Murray, who demonstrated 
blockade with 40 mg/kg of untagged and presumably stabilizer-free  chromic 
phosphate  (5).  Particle size differences  may provide the explanation for this 
disparity. In the present studies blockade was enhanced by reducing particle 
size and the dose of material required to induce blockade could be decreased 
with decreasing particle size. 
This  study has  focused on  early  blockade.  Few other  investigators  have 
concerned themselves with the fate of the blockading dose itself. The present 
studies show that early blockade is detectable only while  the blockading ma- 
terial is still present in the circulation.  Since  chromic  phosphate remains inert 
within the RE cell (16) and is not catabolized like  albumin or gelatin  (6),  it 
is probable that  evidence of late  "blockade" persisting  beyond clearance  of 
the blockading dose has some explanation  other than  that set forth in these 
studies. 
SLI'M~_g~Y 
The  mechanism  of  the  reticuloendothelial  "blockade"  which  followed  in- 
jection of large quantities of chromic phosphate without exogenous stabilizing 
material was investigated in Wistar rats. 
The RE blockade observed for several hours after induction  appeared re- 
lated to the continuing circulation of the chromic phosphate-blockading dose, 
and a reduction in the size of the particles used enhanced blockade. 
RE blockade appeared to be particle specific and was not related to a gen- 
eralized  depression  of RE-phagocytic cell function. DRUTZ, KOENIG~ AND  ROGERS  1097 
Studies  in  isolated perfused  rat livers appeared  to eliminate saturation  of 
particle-specific macrophage clones  as a  likely explanation  of blockade,  and 
blockade could not be explained on the basis of depletion of serum opsonins. 
In the  system employed, it  is postulated  that blockade occurs when large 
numbers of circulating particles saturate specific macrophage cell membrane- 
binding sites rather than from physical stuffang of RE-phagocytic cells. 
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EXPLANATION OF PLATE 85 
FIG.  1.  Electron photomicrograph of chromic phosphate  in  distilled  water.  The 
heterogeneity  of  the  particle  population  is  evident.  The  majority  of  the  particles 
measure approximately 0.9  X 0.9/z, while the largest are 0.9  ×  1.4 #. Note, however, 
the presence of many smaller particles. Some clumping occurs in the electron micros- 
copy-fixation process.  X  6160. 
FIG. 2 a.  The appearance of the liver  1 hr following  the intravenous injection of 
1000 mg/kg of untagged chromic phosphate.  Note the chromic phosphate particles 
within Kupffer's cells lining hepatic sinusoids.  X  2000. 
FIG. 2 b. The appearance of the liver  1 hr following  the intravenous injection of 
1000 mg/kg of untagged chromic phosphate.  Note that some chromic phosphate is 
within Kupffer's cells, some lies free within the lumen of the sinusoids,  some adheres 
to the surface of Kupffer's cells,  and  some lines  the endothelium  of the sinusoids. 
×  2000. 
FIG. 3 a-3 c.  The appearance of the isolated perfused liver after perfusion of tracer 
amounts  of  radiolabeled  chromic phosphate.  Note  the  chromic  phosphate  within 
hepatic Kupffer's cells and also adhering to the endothelial lining of hepatic sinusoids. 
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